Definium Therapeutics Inc. Common Shares vs James Hardie Industries plc. Ordinary Shares — how do they compare? Definium Therapeutics Inc. Common Shares trades at $37.05 (market cap $4.59B), while James Hardie Industries plc. Ordinary Shares trades at $25.06 (market cap $14.60B). The key difference: James Hardie Industries plc. Ordinary Shares is far larger — about 3.2× Definium Therapeutics Inc. Common Shares's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, James Hardie Industries plc. Ordinary Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and James Hardie Industries plc. Ordinary Shares for 1 Days on average.
| DFTX | JHX | |
|---|---|---|
Market Cap | $4.59B | $14.60B |
Volume | 2,103,937 | 7,262,924 |
Sector | Health | Basic Materials |
52-Week High | $48.45 | $31.08 |
52-Week Low | $10.68 | $16.69 |
Typical Hold Time | 0 Days | 1 Days |
Enterprise Value | $3.55B | $18.83B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →James Hardie manufactures fiber cement products for residential and commercial construction. Its portfolio includes exterior siding, interior boards, and other building materials.
Read more on JHX →